- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Infection rate of vaccinated exceed that of unvaccinated in the UK. New data
Posted on 10/10/21 at 6:18 pm
Posted on 10/10/21 at 6:18 pm
The covid infection rates among the vaccinated now exceed the unvaxxed in every age group over 30. you can grab raw data here.
LINK
LINK
Posted on 10/10/21 at 6:18 pm to GodnCountry
(no message)
This post was edited on 11/14/23 at 12:33 am
Posted on 10/10/21 at 6:21 pm to TomBuchanan
quote:
In before Eurocat "tells" you why your stats are wrong
his copy/paste keys are getting worn out today from his Daily Marxist Propaganda newsletter
Posted on 10/10/21 at 6:23 pm to GodnCountry
shite wanes in effectiveness.
Everyone is gonna get Rona.
Your choice with or without a shot.
Everyone is gonna get Rona.
Your choice with or without a shot.
Posted on 10/10/21 at 6:25 pm to GodnCountry
Yeh the vaccine doesn’t work. Everyone just needs to get it and move on.
Posted on 10/10/21 at 6:27 pm to Uncle Stu
His copy and paste is a case against mandates. With over 100m already having covid, and those vaccination rates, we should be lifting the shackles from everything
Posted on 10/10/21 at 6:29 pm to tigafan4life
quote:
vaccine doesn't work
It's certainly not a "vaccine".
But, it certainly has reduced deaths in older people.
I worry that will change with decreasing effectiveness over time.
I kinda think it'd be best my parents get Rona now. Before their shots want in effectiveness too much.
Posted on 10/10/21 at 6:29 pm to GodnCountry
What is Biden going to do to protect me from the vaccinated? I don’t feel safe. Need to fine companies for having employees who are vaccinated. The risks are too great not to.
Posted on 10/10/21 at 6:30 pm to GodnCountry
The original source material linked doesn't match the alarmist headline -
Vaccine effectiveness
Large clinical trials have been undertaken for each of the COVID-19 vaccines approved in the
UK which found that they are highly efficacious at preventing symptomatic disease in the
populations that were studied. The clinical trials have been designed to be able to assess the
efficacy of the vaccine against laboratory confirmed symptomatic disease with a relatively short
follow up period so that effective vaccines can be introduced as rapidly as possible.
Nevertheless, understanding the effectiveness against different outcomes (such as severe
disease and onwards transmission), effectiveness in different subgroups of the population and
understanding the duration of protection are equally important in decision making around which
vaccines should be implemented as the programme evolves, who they should be offered to and
whether booster doses are required.
Vaccine effectiveness is estimated by comparing rates of disease in vaccinated individuals to
rates in unvaccinated individuals. Below we outline the latest real-world evidence on vaccine
effectiveness from studies in UK populations. We focus on data related to the Delta variant
which is currently dominant in the UK. The findings are also summarised in Table 1.
Effectiveness against symptomatic disease
Vaccine effectiveness against symptomatic COVID-19 has been assessed in England based on
community testing data linked to vaccination data from the National Immunisation Management
System (NIMS), cohort studies such as the COVID Infection Survey and GP electronic health
record data. After 2 doses, observed vaccine effectiveness against symptomatic disease with
the Delta variant reaches approximately 65 to 70% with AstraZeneca Vaxzevria and 80 to 95%
with Pfizer-BioNTech Comirnaty and Moderna Spikevax (3, 4) Vaccine effectiveness is
generally slightly higher in younger compared to older age groups. With both Vaxzevria and and
Comirnaty, there is evidence of waning of protection over time, most notably among older
adults. There is not yet enough follow-up with Spikevax to assess waning (3).
Data (based primarily on the Alpha variant) suggest that in most clinical risk groups, immune
response to vaccination is maintained and high levels of VE are seen with both the Pfizer and
AstraZeneca vaccines. Reduced antibody response and vaccine effectiveness were seen after
1 dose of vaccine among the immunosuppressed group, however, after a second dose the
reduction in vaccine effectiveness is smaller (5).
Analyses by dosing interval suggest that immune response to vaccination and vaccine
effectiveness against symptomatic disease improves with a longer (greater than 6 week
interval) compared to a shorter interval of 3 to 4 weeks (6, 3)
COVID-19 vaccine surveillance report – week 40
5
Effectiveness against hospitalisation
Several studies have estimated vaccine effectiveness against hospitalisation in older all of
which indicate higher levels of protection against hospitalisation with all vaccines against the
Alpha variant (7, 8, 9, 10). Effectiveness against hospitalisation of over 90% is also observed
with the Delta variant with all 3 vaccines (3). In most groups there is relatively limited waning of
protection against hospitalisation over a period of at least 5 months after the second dose.
Greater waning appears to occur among those in clinical risk groups (3).
Effectiveness against mortality
High levels of protection (over 90%) are also seen against mortality with all 3 vaccines and
against both the Alpha and Delta variants (7, 11, 3). Relatively limited waning of protection
against mortality is seen over a period of at least 5 months.
Effectiveness against transmitssion
As described above, several studies have provided evidence that vaccines are effective at
preventing infection. Uninfected individuals cannot transmit; therefore, the vaccines are also
effective at preventing transmission. There may be additional benefit, beyond that due to
prevention of infection, if some of those individuals who become infected despite vaccination
are also at a reduced risk of transmitting (for example, because of reduced duration or level of
viral shedding). A household transmission study in England found that household contacts of
cases vaccinated with a single dose had approximately 35 to 50% reduced risk of becoming a
confirmed case of COVID-19. This study used routine testing data so would only include
household contacts that developed symptoms and went on to request a test via pillar 2. It
cannot exclude asymptomatic secondary cases or mildly symptomatic cases who chose not to
request a COVID-19 test (16). Data from Scotland has also shown that household contacts of
vaccinated healthcare workers are at reduced risk of becoming a case, which is in line with the
studies on infection (17). Both of these studies relate to a period when the Alpha variant
dominated. An analysis from the ONS Community Infection Survey found that contacts of
vaccinated index cases had around 65-80% reduced odds of testing positive with the Alpha
variant and 35-65% reduced odds of testing positive with the Delta variant compare to contacts
of unvaccinated index cases (18).
COVID-19 vaccine surveillance report – week 40
7
A summary of vaccine effectiveness evidence can be seen in Table 1.
Vaccine effectiveness
Large clinical trials have been undertaken for each of the COVID-19 vaccines approved in the
UK which found that they are highly efficacious at preventing symptomatic disease in the
populations that were studied. The clinical trials have been designed to be able to assess the
efficacy of the vaccine against laboratory confirmed symptomatic disease with a relatively short
follow up period so that effective vaccines can be introduced as rapidly as possible.
Nevertheless, understanding the effectiveness against different outcomes (such as severe
disease and onwards transmission), effectiveness in different subgroups of the population and
understanding the duration of protection are equally important in decision making around which
vaccines should be implemented as the programme evolves, who they should be offered to and
whether booster doses are required.
Vaccine effectiveness is estimated by comparing rates of disease in vaccinated individuals to
rates in unvaccinated individuals. Below we outline the latest real-world evidence on vaccine
effectiveness from studies in UK populations. We focus on data related to the Delta variant
which is currently dominant in the UK. The findings are also summarised in Table 1.
Effectiveness against symptomatic disease
Vaccine effectiveness against symptomatic COVID-19 has been assessed in England based on
community testing data linked to vaccination data from the National Immunisation Management
System (NIMS), cohort studies such as the COVID Infection Survey and GP electronic health
record data. After 2 doses, observed vaccine effectiveness against symptomatic disease with
the Delta variant reaches approximately 65 to 70% with AstraZeneca Vaxzevria and 80 to 95%
with Pfizer-BioNTech Comirnaty and Moderna Spikevax (3, 4) Vaccine effectiveness is
generally slightly higher in younger compared to older age groups. With both Vaxzevria and and
Comirnaty, there is evidence of waning of protection over time, most notably among older
adults. There is not yet enough follow-up with Spikevax to assess waning (3).
Data (based primarily on the Alpha variant) suggest that in most clinical risk groups, immune
response to vaccination is maintained and high levels of VE are seen with both the Pfizer and
AstraZeneca vaccines. Reduced antibody response and vaccine effectiveness were seen after
1 dose of vaccine among the immunosuppressed group, however, after a second dose the
reduction in vaccine effectiveness is smaller (5).
Analyses by dosing interval suggest that immune response to vaccination and vaccine
effectiveness against symptomatic disease improves with a longer (greater than 6 week
interval) compared to a shorter interval of 3 to 4 weeks (6, 3)
COVID-19 vaccine surveillance report – week 40
5
Effectiveness against hospitalisation
Several studies have estimated vaccine effectiveness against hospitalisation in older all of
which indicate higher levels of protection against hospitalisation with all vaccines against the
Alpha variant (7, 8, 9, 10). Effectiveness against hospitalisation of over 90% is also observed
with the Delta variant with all 3 vaccines (3). In most groups there is relatively limited waning of
protection against hospitalisation over a period of at least 5 months after the second dose.
Greater waning appears to occur among those in clinical risk groups (3).
Effectiveness against mortality
High levels of protection (over 90%) are also seen against mortality with all 3 vaccines and
against both the Alpha and Delta variants (7, 11, 3). Relatively limited waning of protection
against mortality is seen over a period of at least 5 months.
Effectiveness against transmitssion
As described above, several studies have provided evidence that vaccines are effective at
preventing infection. Uninfected individuals cannot transmit; therefore, the vaccines are also
effective at preventing transmission. There may be additional benefit, beyond that due to
prevention of infection, if some of those individuals who become infected despite vaccination
are also at a reduced risk of transmitting (for example, because of reduced duration or level of
viral shedding). A household transmission study in England found that household contacts of
cases vaccinated with a single dose had approximately 35 to 50% reduced risk of becoming a
confirmed case of COVID-19. This study used routine testing data so would only include
household contacts that developed symptoms and went on to request a test via pillar 2. It
cannot exclude asymptomatic secondary cases or mildly symptomatic cases who chose not to
request a COVID-19 test (16). Data from Scotland has also shown that household contacts of
vaccinated healthcare workers are at reduced risk of becoming a case, which is in line with the
studies on infection (17). Both of these studies relate to a period when the Alpha variant
dominated. An analysis from the ONS Community Infection Survey found that contacts of
vaccinated index cases had around 65-80% reduced odds of testing positive with the Alpha
variant and 35-65% reduced odds of testing positive with the Delta variant compare to contacts
of unvaccinated index cases (18).
COVID-19 vaccine surveillance report – week 40
7
A summary of vaccine effectiveness evidence can be seen in Table 1.
Posted on 10/10/21 at 6:36 pm to GodnCountry
I’ll just post this tidbit of the author’s of the report in which GP got their raw data from.
Sorry to rain on y’all’s parade but this is not evidence to support your incorrect opinions on the COVID-19 vaccines.
quote:
These data should be considered in the context of vaccination status of the population groups shown in the rest of this report. The vaccination status of cases, inpatients and deaths is not the most appropriate method to assess vaccine effectiveness and there is a high risk of misinterpretation. Vaccine effectiveness has been formally estimated from a number of different sources and is described earlier in this report.
In the context of very high vaccine coverage in the population, even with a highly effective vaccine, it is expected that a large proportion of cases, hospitalisations and deaths would occur in vaccinated individuals, simply because a larger proportion of the population are vaccinated than unvaccinated and no vaccine is 100% effective. This is especially true because vaccination has been prioritised in individuals who are more susceptible or more at risk of severe disease. Individuals in risk groups may also be more at risk of hospitalisation or death due to non- COVID-19 causes, and thus may be hospitalised or die with COVID-19 rather than because of COVID-19.
Sorry to rain on y’all’s parade but this is not evidence to support your incorrect opinions on the COVID-19 vaccines.
Posted on 10/10/21 at 6:41 pm to Eurocat
(no message)
This post was edited on 11/14/23 at 12:35 am
Posted on 10/10/21 at 6:44 pm to TomBuchanan
quote:
quote:
The original source material linked doesn't match the alarmist headline -
You are as predictable as the sun rising tomorrow
Came back to check your prediction.
Right you are. LOL
Posted on 10/10/21 at 6:51 pm to TomBuchanan
Well thanks a lot . Now Eurocat with find data to show us that although tomorrow might come that doesn’t mean the sun will rise
Posted on 10/10/21 at 6:53 pm to tigafan4life
quote:
Yeh the vaccine doesn’t work. Everyone just needs to get it and move on.
You failed to finish your post…..
quote:
Yeh the vaccine doesn’t work. Everyone just needs to get it and move on.
Signed,
The Current Authoritarian Marxist Regime
Posted on 10/10/21 at 7:02 pm to WeeWee
quote:
Sorry to rain on y’all’s parade but this is not evidence to support your incorrect opinions on the COVID-19 vaccines.
It doesn't? Why? Because they are finally going to admit that it doesn't stop you from getting the virus?
Funny thing about these charts:
1) they clearly show that it doesn't stop infection, even with a large percentage of the population vaccinated (78% fully vaccinated, with estimates that upwards of 98% of the population has antibodies).
2) they clearly show that it greatly decreases hospitalizations and deaths.
So based on these two bits of data, why is it necessary to force the vaccine on people? If you want it, get it. The UK data shows pretty clearly it protects you pretty well from the worst outcomes.
So vaccinated people don't need to worry about the unvaccinated.
Posted on 10/10/21 at 7:04 pm to Nosevens
quote:the sun just sits there.
Now Eurocat with find data to show us that although tomorrow might come that doesn’t mean the sun will rise
The earth spins.
Like eurocat
Posted on 10/10/21 at 7:23 pm to Privateer 2007
quote:
It's certainly not a "vaccine".
But, it certainly has reduced deaths in older people.
No sir. What you meant to say is that the Delta variant is not as lethal like every other virus known to man.
Posted on 10/10/21 at 7:24 pm to Eurocat
And there he is! LOL
A total ignore of the chart in the OP and YES.,... That chart is IN the report.
A total ignore of the chart in the OP and YES.,... That chart is IN the report.
Posted on 10/10/21 at 7:26 pm to GodnCountry
Debate the mandates all you want, but this was bound to happen once the pool of vaccinated was larger than the pool of unvaccinated.
Popular
Back to top
Follow TigerDroppings for LSU Football News